FDA Accepts & Gives Priority Review to Intellia's BLA for HAE Drug

Novartis' Del-desiran Fails Late-Stage DM1 Study, Shares Fall

Roche Gets FDA Priority Tag for Enspryng in Rare Autoimmune Disorder

Immunocore Hits Enrollment Target in Kimmtrak Label Expansion Study

RCKT Aligns With FDA on Completing Phase II Study in Danon Disease

PBYI's Alisertib Combo Phase II Study in Small Cell Lung Cancer Begins

NVS Gets Positive CHMP Opinion for Cosentyx for Another Indication

AMGN's Dazodalibep Meets Goal in Systemic Sjogren's Disease Study

Merck's Remigromig Meets Main Goal in Diabetic Macular Edema Study

Is Anika Therapeutics (ANIK) Outperforming Other Medical Stocks This Year?